RHÖN-KLINIKUM AG Announces Positive Financial Results for 2023

RHÖN-KLINIKUM AG has achieved its financial goals for the fiscal year 2023, posting significant gains in revenue and profit. The company reports a revenue increase of 17.9 million euros, totaling 1,464.0 million euros, surpassing the previous year's figure despite the end of COVID-19 related reimbursements. The consolidated profit rose by 13.3 million euros, reaching 40.2 million euros, while EBITDA remained stable at 105.9 million euros. Patient care numbers also increased, with a 3.1% rise in treated patients.

Prof. Dr. Tobias Kaltenbach, Board Chairman, emphasized the company's solid performance amid Germany's challenging hospital economic landscape. The strategic focus for RHÖN-KLINIKUM AG has been on optimizing inpatient services, expanding outpatient care, advancing digitalization, and streamlining processes. Moreover, the company has committed to achieving CO2-greenhouse gas neutrality for Scope 1 and 2 emissions by 2040, adopting sustainable technologies and optimizing site processes.

Looking ahead to 2024, RHÖN-KLINIKUM AG forecasts revenues of approximately 1.6 billion euros, with EBITDA expectations ranging from 110 million euros to 120 million euros. This outlook acknowledges potential uncertainties including regulatory changes and global economic crises. RHÖN-KLINIKUM AG reaffirms its position as a leading healthcare provider in Germany, focusing on innovative and sustainable healthcare solutions.